IR-led deep ketamine sedation for select image-guided procedures
Official title: Prospective Single-Arm Feasibility Study of IR-led Deep Sedation for Interventional Radiology Procedures Traditionally Performed With Anesthesiology Support
Run by CAMC Health System · NCT07443254 · Data updated 2026-11-12
We will try deep ketamine sedation instead of general anesthesia for adults having certain image-guided interventional radiology procedures.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | CAMC Health System Academic / other |
| Locations | 1 site (Charleston, West Virginia) |
| Status | Recruiting |
| Started | March 2, 2026 |
| Main results expected | April 3, 2027 |
| Study ends | April 3, 2027 |
| Registry record updated | March 9, 2026 |
| Trial ID | NCT07443254 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) scheduled for image-guided IR procedures that the performing IR physician would normally request general anesthesia for, who are deemed appropriate for IR-led ketamine deep sedation and can provide informed consent, are the ideal candidates.
✕Probably not a fit
Patients with contraindications to ketamine or its co-medications, uncontrolled hypertension or other conditions that make ketamine unsafe, pregnancy or lactation, inability to consent, or those requiring airway management are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center, single-arm feasibility pilot will test whether interventional radiology (IR) teams can safely provide ketamine-based deep sedation for procedures that would ordinarily require general anesthesia. The study will begin with 20 adults and may expand to 40 if prespecified safety and feasibility criteria are met. Ketamine (with fentanyl and midazolam as needed) will be administered by the IR sedation team under institutional deep sedation protocols while anesthesiology is consulted in advance and available for immediate escalation. The primary outcome is procedural feasibility (completion without abortion or escalation to general anesthesia); secondary outcomes include patient-reported pain and satisfaction, peri-procedural adverse events, and recovery duration.
Why it matters
Potential benefit: If successful, this approach could let eligible patients avoid general anesthesia and its airway risks while conserving anesthesia resources and potentially shortening recovery.
How similar studies have gone: Ketamine-based deep sedation has been used in other procedural settings, but IR-led substitution for general anesthesia is relatively novel and not yet widely validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 and older * Planned to undergo an image-guided IR procedure for which general anesthesia would ordinarily be requested, as determined by the performing IR physician * Determined by the performing IR physician to be an appropriate candidate for attempted IR-led ketamine- based deep sedation, with anesthesiology available for escalation if needed * Ability to provide written informed consent for participation in a study involving deep sedation Exclusion Criteria: * Ingestion of solid food within 6-8 hours prior to the procedure, per institutional deep sedation guidelines * Known allergy or hypersensitivity to ketamine, fentanyl or midazolam * Inability to provide informed consent or lack of decision-making capacity * Prisoner status * Uncontrolled hypertension or other condition in which ketamine-associated sympathetic stimulation would pose unacceptable risk (e.g., aortic dissection, acute myocardial infarction) * Pregnancy or lactation, due to contraindication to ketamine/midazolam * History of schizophrenia or other psychotic disorders for which ketamine is contraindicated * Medical conditions that, in the judgment of the performing IR physician in consultation with anesthesiology, preclude safe administration of ketamine-based deep sedation
Where it's running
-
CAMC Memorial
Charleston, West Virginia, United States Recruiting
Study contacts
- Principal investigator: Amy R Deipolyi, M.D., Ph.D. — CAMC Department of Interventional Radiology
- Study coordinator: Amy R Deipolyi, M.D., Ph.D.
- Email: Amy.Deipolyi@vandaliahealth.org
- Phone: 304-388-8199
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ketamine-Propofol vs Dexmedetomidine-Propofol Sedation for Pediatric Cardiac Catheterization
This study tests two sedative combinations to see which is safer and more effective for children 2–12 undergoing device closure of simple left-to-right heart shunts.
-
Impact of Anesthesia on Inflammation and NETosis During HCC Ablation
This study tests whether a propofol–fentanyl anesthesia plan with lidocaine during radiofrequency ablation for hepatocellular carcinoma affects inflammation and NETosis in patients with small tumors.
-
Cannabis use and IV sedation during wisdom tooth removal
This project will see if people who use cannabis need different IV sedative doses or have different vital signs and breathing during wisdom tooth removal compared with people who don't use cannabis.
-
Brain‑wave and pain‑signal monitoring during anesthesia for ERCP to map opioid and sedative effects
This trial will test whether continuous brain‑wave (EEG/PSI) and heart‑rate variability (ANI) monitoring during targeted infusions of opioids and sedatives can show how those drugs interact in people having ERCP under general anesthesia.
-
How common pain is in adults on mechanical ventilators in intensive care units
The researchers will measure how often adults on invasive mechanical ventilation in ICUs experience pain and which clinical factors are linked to it.
-
No continuous sedation versus daily sedation interruption for ventilated COPD patients
This compares no continuous sedation to daily sedation breaks to see which approach gives more ventilator-free days for adults with COPD on a breathing machine.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.